Oncology
5,176 studies502 in 7 days2,477 in 30 days
Filters
Latest
5,176 studies
- Consolidation immunotherapy after concurrent chemoradiotherapy enabling conversion surgery for stage IIIB pulmonary NUT carcinoma: a case report and literature review
- Spindle cell/pleomorphic lipoma causing complete obstruction of the left main bronchus: a case report
- Ultrasound-based radiomics for phyllodes tumor diagnosis: A comprehensive single-center study with extensive patient cohort
- A TLS-associated immune-activation transcriptomic score is associated with prognosis and the immune landscape in breast cancer
- Case Report: BARD1 p.Val507Met in two relatives with ER-positive breast cancer: cascade testing and exploratory longitudinal cfDNA dynamics
- Proteomics and phosphoproteomics analysis of diffuse large B-cell lymphoma based on PD-L1 expression subtyping
- Epidemiological trends, projections, and attributable risk factors of esophageal cancer: a comparative study of four Western Pacific countries, 1990–2040
- Associations of obesity and visceral adiposity with overall survival and immune-related adverse events in patients with endometrial cancer treated with immunotherapy: a retrospective analysis
- Optimizing Immunohistochemical Surrogate Panels for 1p/19q Codeletion in IDH-Mutant Adult Diffuse Gliomas: Diagnostic Performance of Vimentin and H3K27me3
- Vascular and Circulating Blood Exposure to Proton or Photon Irradiation: Differentials in Lymphocyte Subset Metrics in Cancer Patients
- SMYD2 in Hepatocellular Carcinoma: An Emerging Epigenetic Link Between Tumor Cell Programs and Microenvironmental Dynamics
- 1111 NIR light mediated mechanical destruction of glioma cells to trigger tumor antigen release and potentiate immunogenic cell death
- 147 JAK1- altered checkpoint inhibitor-resistant melanoma treated with intratumoral oncolytic viral therapy: a 2-patient case series
- 601 GARP–TGF-β1 blockade with livmoniplimab reprograms spatial tumor niches and enhances PD-1 inhibition in human tumor explants
- 1153 Melanocyte PD-L1 and type I interferons (IFN-Is) promote metastasis and immune suppression in UVB-associated melanoma
- 914 Dual-antigen targeting via a PMPC-engineered bispecific ADC overcomes tumor heterogeneity and enhances anti-tumor efficacy in advanced ovarian cancer
- 542 A first-in-human phase 1/2 study of XTX501, a bispecific PD-1/masked IL-2, in metastatic non-small cell lung cancer (NSCLC)
- 606 Transport vehicle-enabled TREM2 agonist therapy potentiates anti-tumor immunity in preclinical mouse models of GBM
- 241 Engineering CAR-T cell resistance to CAF-derived paracrine cAMP-mediated immunosuppression
- 19 Single-cell biophysical profiling as an early predictor of tumor reactivity in tumor-infiltrating lymphocyte manufacturing
- BCAR4, BCAR3 and EGFR Display Different Degrees of Cross-Resistance to Endocrine Mono- and Combination Therapies in Hormone Receptor Positive, HER2 Negative Breast Cancer
- Preoperative Aggregate Index of Systemic Inflammation and Serum 3 Hsa_circ_0076251 are Associated with the 2- Year Recurrence of Stage II/III 4 Colorectal Cancer: A Single- Center
- Integrated tumor and circulating immune profiling in the NEO-CESQ trial of perioperative cemiplimab for resectable cutaneous squamous cell carcinoma
- Tracing specificity of immune landscape remodeling associated with distinct anticancer treatments
- 1180 Interim safety and efficacy results of Victoria-01: a phase 1 study to evaluate the safety and preliminary efficacy of SOT201 in patients with advanced/metastatic solid tumors